Joanne Wuensch
Stock Analyst at Citigroup
(4.35)
# 343
Out of 4,944 analysts
399
Total ratings
62.17%
Success rate
11.72%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Upgrades: Neutral | $10 → $10 | $11.67 | -11.31% | 18 | Aug 12, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $89 → $93 | $74.75 | +24.41% | 6 | Jul 31, 2025 | |
| PEN Penumbra | Maintains: Neutral | $320 → $285 | $252.47 | +12.88% | 25 | Jul 9, 2025 | |
| MDT Medtronic | Maintains: Buy | $98 → $99 | $92.26 | +7.31% | 20 | Jul 9, 2025 | |
| ESTA Establishment Labs Holdings | Maintains: Neutral | $38 → $47 | $35.85 | +31.10% | 7 | Jul 9, 2025 | |
| BAX Baxter International | Maintains: Neutral | $34 → $32 | $23.92 | +33.78% | 21 | Jul 9, 2025 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $13 → $15 | $14.15 | +6.01% | 6 | Jul 9, 2025 | |
| HAE Haemonetics | Upgrades: Buy | $71 → $90 | $53.00 | +69.81% | 8 | Jul 9, 2025 | |
| SYK Stryker | Maintains: Buy | $443 → $455 | $375.02 | +21.33% | 14 | May 22, 2025 | |
| SGHT Sight Sciences | Maintains: Neutral | $3.2 → $3.6 | $4.25 | -15.29% | 11 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6.5 → $4.15 | $1.59 | +161.83% | 12 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $167 | $165.00 | +1.21% | 19 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $590 → $650 | $475.91 | +36.58% | 17 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $380 | $312.81 | +21.48% | 16 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $95 | $76.90 | +23.54% | 20 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $82 → $102 | $80.66 | +26.46% | 14 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $119 → $125 | $101.82 | +22.77% | 35 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $133 → $140 | $108.64 | +28.87% | 6 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $110 | $74.01 | +48.63% | 20 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $160 | $128.96 | +24.07% | 20 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $175 | $173.58 | +0.82% | 12 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $132 → $162 | $91.39 | +77.26% | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $16 → $22 | $14.03 | +56.81% | 14 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $134 → $120 | $102.41 | +17.18% | 22 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $220 → $250 | $194.95 | +28.24% | 5 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $67 → $69 | $86.75 | -20.46% | 5 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $109 → $127 | $287.47 | -55.82% | 6 | Dec 10, 2018 |
Tandem Diabetes Care
Aug 12, 2025
Upgrades: Neutral
Price Target: $10 → $10
Current: $11.67
Upside: -11.31%
GE HealthCare Technologies
Jul 31, 2025
Maintains: Buy
Price Target: $89 → $93
Current: $74.75
Upside: +24.41%
Penumbra
Jul 9, 2025
Maintains: Neutral
Price Target: $320 → $285
Current: $252.47
Upside: +12.88%
Medtronic
Jul 9, 2025
Maintains: Buy
Price Target: $98 → $99
Current: $92.26
Upside: +7.31%
Establishment Labs Holdings
Jul 9, 2025
Maintains: Neutral
Price Target: $38 → $47
Current: $35.85
Upside: +31.10%
Baxter International
Jul 9, 2025
Maintains: Neutral
Price Target: $34 → $32
Current: $23.92
Upside: +33.78%
Bausch + Lomb
Jul 9, 2025
Maintains: Neutral
Price Target: $13 → $15
Current: $14.15
Upside: +6.01%
Haemonetics
Jul 9, 2025
Upgrades: Buy
Price Target: $71 → $90
Current: $53.00
Upside: +69.81%
Stryker
May 22, 2025
Maintains: Buy
Price Target: $443 → $455
Current: $375.02
Upside: +21.33%
Sight Sciences
May 22, 2025
Maintains: Neutral
Price Target: $3.2 → $3.6
Current: $4.25
Upside: -15.29%
May 22, 2025
Maintains: Neutral
Price Target: $6.5 → $4.15
Current: $1.59
Upside: +161.83%
May 22, 2025
Maintains: Buy
Price Target: $130 → $167
Current: $165.00
Upside: +1.21%
May 22, 2025
Maintains: Buy
Price Target: $590 → $650
Current: $475.91
Upside: +36.58%
May 22, 2025
Maintains: Buy
Price Target: $320 → $380
Current: $312.81
Upside: +21.48%
May 22, 2025
Maintains: Buy
Price Target: $84 → $95
Current: $76.90
Upside: +23.54%
May 22, 2025
Maintains: Buy
Price Target: $82 → $102
Current: $80.66
Upside: +26.46%
May 22, 2025
Maintains: Buy
Price Target: $119 → $125
Current: $101.82
Upside: +22.77%
May 22, 2025
Upgrades: Buy
Price Target: $133 → $140
Current: $108.64
Upside: +28.87%
Mar 7, 2025
Maintains: Buy
Price Target: $115 → $110
Current: $74.01
Upside: +48.63%
Mar 4, 2025
Maintains: Buy
Price Target: $135 → $160
Current: $128.96
Upside: +24.07%
Dec 11, 2024
Maintains: Buy
Price Target: $185 → $175
Current: $173.58
Upside: +0.82%
Dec 11, 2024
Upgrades: Buy
Price Target: $132 → $162
Current: $91.39
Upside: +77.26%
Nov 5, 2024
Maintains: Sell
Price Target: $16 → $22
Current: $14.03
Upside: +56.81%
Jul 10, 2024
Maintains: Neutral
Price Target: $134 → $120
Current: $102.41
Upside: +17.18%
Dec 12, 2022
Upgrades: Neutral
Price Target: $220 → $250
Current: $194.95
Upside: +28.24%
Nov 17, 2022
Maintains: Neutral
Price Target: $67 → $69
Current: $86.75
Upside: -20.46%
Dec 10, 2018
Upgrades: Outperform
Price Target: $109 → $127
Current: $287.47
Upside: -55.82%